utilized a mouse model of bleomycin (BLM)-induced pulmonary fibrosis and evaluated the fibrotic potential of the IL-33-mediated ST2 signaling pathway using a therapeutic dose of ST2-Fc fusion protein. The gene discussed is IL1RL1; the disease is pulmonary fibrosis.